We are live on ! Find out more
HCAT icon

Health Catalyst
HCAT

86 hedge funds and large institutions have $523M invested in Health Catalyst in 2019 Q3 according to their latest regulatory filings, with 86 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

45.75% more ownership

Funds ownership: 0% → 45.75% (+46%)

Holders
86
Holders Change
+86
Holders Change %
–
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
86
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SUT
SC US (TTGP)
California
+$243M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$45.5M
3
Sands Capital Management
Sands Capital Management
Virginia
+$35M
4
Victory Capital Management
Victory Capital Management
Texas
+$32.8M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$28.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SUT
1
SC US (TTGP)
California
$195M +$243M +6,178,381 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$36.6M +$45.5M +1,155,284 New
Victory Capital Management
3
Victory Capital Management
Texas
$26.4M +$32.8M +834,253 New
Sands Capital Management
4
Sands Capital Management
Virginia
$23.5M +$35M +889,146 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$23M +$28.6M +725,676 New
BlackRock
6
BlackRock
New York
$20.1M +$25M +633,957 New
Wells Fargo
7
Wells Fargo
California
$19.3M +$24M +609,187 New
American Century Companies
8
American Century Companies
Missouri
$16.1M +$20.1M +509,594 New
Alkeon Capital Management
9
Alkeon Capital Management
New York
$15.9M +$19.8M +502,500 New
AllianceBernstein
10
AllianceBernstein
Tennessee
$13.7M +$17.1M +433,444 New
Capital International Investors
11
Capital International Investors
California
$12.7M +$15.7M +400,000 New
ClearBridge Investments
12
ClearBridge Investments
New York
$10.2M +$12.6M +320,970 New
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$9.52M +$11.8M +300,736 New
Capital Research Global Investors
14
Capital Research Global Investors
California
$7.06M +$8.78M +223,100 New
PA
15
Perceptive Advisors
New York
$6.67M +$8.3M +210,924 New
O
16
OrbiMed
New York
$5.68M +$7.07M +179,598 New
Lord, Abbett & Co
17
Lord, Abbett & Co
New Jersey
$5.46M +$6.8M +172,669 New
BG
18
Bellevue Group
Switzerland
$5.07M +$6.31M +160,216 New
Janus Henderson Group
19
Janus Henderson Group
United Kingdom
$4.37M +$5.43M +138,033 New
State Street
20
State Street
Massachusetts
$4.12M +$5.12M +130,185 New
RSCM
21
Rock Springs Capital Management
Maryland
$3.96M +$4.92M +125,000 New
Northern Trust
22
Northern Trust
Illinois
$3.43M +$4.27M +108,382 New
CCA
23
Conestoga Capital Advisors
Pennsylvania
$3.25M +$4.04M +102,690 New
TAM
24
Tiverton Asset Management
Delaware
$3.18M +$3.95M +100,444 New
NI
25
Nepsis Inc
Minnesota
$3.1M +$4.28M +108,702 New
1
2 3 4

HCAT Hedge Fund Activity: Q3 2019 in Review

86 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q3 2019, worth a combined $523M.

Buyers outnumbered sellers: 86 funds opened new HCAT positions and 0 closed out — a net gain of 86 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was SC US (TTGP), opening a new position worth an estimated $243M.

  • 86 institutional investors held Health Catalyst (HCAT) as of Q3 2019, up from 0 in Q2 2019.
  • Funds reported $523M of Health Catalyst stock for Q3 2019.
  • 86 funds opened new Health Catalyst positions in Q3 2019 and 0 closed out, a net change of +86 holders.
  • The largest Health Catalyst buyer in Q3 2019 was SC US (TTGP), an estimated $243M added.

Based on aggregated 13F filings for Q3 2019.